FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023702382> ?p ?o ?g. }

• W2023702382 endingPage "310" @default.
• W2023702382 startingPage "304" @default.
• W2023702382 abstract "Autoantibodies were studied in a well-characterized cohort of children with chronic hepatitis C during treatment with pegylated interferon and ribavirin to assess the relation with treatment and development of autoimmune disease.: A total of 114 children (5-17 years), screened for the presence of high-titer autoantibodies, were randomized to pegylated interferon with or without ribavirin. Anti-nuclear, anti-liver-kidney-microsomal, anti-thyroglobulin, anti-thyroid peroxidase, insulin, anti-glutamic acid decarboxylase (GAD) antibodies were measured after trial completion using frozen sera.At baseline, 19% had autoantibodies: anti-nuclear antibodies (8%), anti-liver-kidney-microsomal antibodies (4%), and glutamic acid decarboxylase antibodies (4%). At 24 and 72 weeks (24 weeks after treatment completion), 23% and 26% had autoantibodies (P=0.50, 0.48 compared with baseline). One child developed diabetes and 2 hypothyroidism during treatment; none developed autoimmune hepatitis. At 24 weeks, the incidence of flu-like symptoms, gastrointestinal symptoms, and headaches was 42%, 8% and 19% in those with autoantibodies versus 52%, 17%, and 26% in those without (P=0.18, 0.36, and 0.20, respectively). In children with negative hepatitis C virus polymerase chain reaction at 24 weeks, there was no difference in the rate of early virologic response/sustained virologic response, respectively, in those with autoantibodies 76%/69% vs 58%/65% in those without (P=0.48).Despite screening, we found autoantibodies commonly at baseline, during treatment for chronic hepatitis C and after. The presence of antibodies did not correlate with viral response, adverse effects, or autoimmune hepatitis. Neither screening nor archived samples assayed for thyroid and diabetes-related antibodies identified the 3 subjects who developed overt autoimmune disease, diabetes (1), and hypothyroidism (2)." @default.
• W2023702382 created "2016-06-24" @default.
• W2023702382 creator A5015900335 @default.
• W2023702382 creator A5025247273 @default.
• W2023702382 creator A5038339390 @default.
• W2023702382 creator A5045704318 @default.
• W2023702382 creator A5046466058 @default.
• W2023702382 creator A5046642925 @default.
• W2023702382 creator A5053623460 @default.
• W2023702382 creator A5055145325 @default.
• W2023702382 creator A5056406094 @default.
• W2023702382 creator A5067934543 @default.
• W2023702382 creator A5070318474 @default.
• W2023702382 creator A5079141531 @default.
• W2023702382 creator A5079795365 @default.
• W2023702382 creator A5084776825 @default.
• W2023702382 creator A5089117587 @default.
• W2023702382 creator A5091064969 @default.
• W2023702382 date "2013-03-01" @default.
• W2023702382 modified "2023-10-02" @default.
• W2023702382 title "Autoantibodies and Autoimmune Disease During Treatment of Children With Chronic Hepatitis C" @default.
• W2023702382 cites W1970171323 @default.
• W2023702382 cites W1971011563 @default.
• W2023702382 cites W1983611271 @default.
• W2023702382 cites W2002761055 @default.
• W2023702382 cites W2020317693 @default.
• W2023702382 cites W2031036949 @default.
• W2023702382 cites W2052589536 @default.
• W2023702382 cites W2054638701 @default.
• W2023702382 cites W2056082154 @default.
• W2023702382 cites W2061709969 @default.
• W2023702382 cites W2064870615 @default.
• W2023702382 cites W2065631609 @default.
• W2023702382 cites W2069537429 @default.
• W2023702382 cites W2080733596 @default.
• W2023702382 cites W2081623971 @default.
• W2023702382 cites W2082841886 @default.
• W2023702382 cites W2102008044 @default.
• W2023702382 cites W2111072387 @default.
• W2023702382 cites W2112873828 @default.
• W2023702382 cites W2155674048 @default.
• W2023702382 cites W2158566694 @default.
• W2023702382 cites W2166407844 @default.
• W2023702382 cites W2395546240 @default.
• W2023702382 cites W4232351589 @default.
• W2023702382 doi "https://doi.org/10.1097/mpg.0b013e3182774cae" @default.
• W2023702382 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3583208" @default.
• W2023702382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23439301" @default.
• W2023702382 hasPublicationYear "2013" @default.
• W2023702382 type Work @default.
• W2023702382 sameAs 2023702382 @default.
• W2023702382 citedByCount "16" @default.
• W2023702382 countsByYear W20237023822013 @default.
• W2023702382 countsByYear W20237023822014 @default.
• W2023702382 countsByYear W20237023822015 @default.
• W2023702382 countsByYear W20237023822017 @default.
• W2023702382 countsByYear W20237023822018 @default.
• W2023702382 countsByYear W20237023822021 @default.
• W2023702382 countsByYear W20237023822023 @default.
• W2023702382 crossrefType "journal-article" @default.
• W2023702382 hasAuthorship W2023702382A5015900335 @default.
• W2023702382 hasAuthorship W2023702382A5025247273 @default.
• W2023702382 hasAuthorship W2023702382A5038339390 @default.
• W2023702382 hasAuthorship W2023702382A5045704318 @default.
• W2023702382 hasAuthorship W2023702382A5046466058 @default.
• W2023702382 hasAuthorship W2023702382A5046642925 @default.
• W2023702382 hasAuthorship W2023702382A5053623460 @default.
• W2023702382 hasAuthorship W2023702382A5055145325 @default.
• W2023702382 hasAuthorship W2023702382A5056406094 @default.
• W2023702382 hasAuthorship W2023702382A5067934543 @default.
• W2023702382 hasAuthorship W2023702382A5070318474 @default.
• W2023702382 hasAuthorship W2023702382A5079141531 @default.
• W2023702382 hasAuthorship W2023702382A5079795365 @default.
• W2023702382 hasAuthorship W2023702382A5084776825 @default.
• W2023702382 hasAuthorship W2023702382A5089117587 @default.
• W2023702382 hasAuthorship W2023702382A5091064969 @default.
• W2023702382 hasBestOaLocation W20237023821 @default.
• W2023702382 hasConcept C126322002 @default.
• W2023702382 hasConcept C159654299 @default.
• W2023702382 hasConcept C163764329 @default.
• W2023702382 hasConcept C180650514 @default.
• W2023702382 hasConcept C203014093 @default.
• W2023702382 hasConcept C2522874641 @default.
• W2023702382 hasConcept C2776029263 @default.
• W2023702382 hasConcept C2776408679 @default.
• W2023702382 hasConcept C2776455275 @default.
• W2023702382 hasConcept C2776461080 @default.
• W2023702382 hasConcept C2777203481 @default.
• W2023702382 hasConcept C2780040827 @default.
• W2023702382 hasConcept C71924100 @default.
• W2023702382 hasConcept C90924648 @default.
• W2023702382 hasConceptScore W2023702382C126322002 @default.
• W2023702382 hasConceptScore W2023702382C159654299 @default.
• W2023702382 hasConceptScore W2023702382C163764329 @default.
• W2023702382 hasConceptScore W2023702382C180650514 @default.
• W2023702382 hasConceptScore W2023702382C203014093 @default.
• W2023702382 hasConceptScore W2023702382C2522874641 @default.
• W2023702382 hasConceptScore W2023702382C2776029263 @default.

• next